Ning B, Xu D-L, Gao J-H, Wang L-L, Yan S-Y, Cheng S
Department of Orthopaedics, People's Hospital of Dongying, Dongying, Shandong Province, China.
Eur Rev Med Pharmacol Sci. 2016 Jun;20(11):2209-20.
The objective of this paper is to identify pathway-related modules which are defined as in high-grade osteosarcoma based on topological centralities analysis of networks.
Co-expression network was constructed by weighted gene co-expression network analysis (WGCNA) based on differentially expressed genes (DEGs). Pathway enrichment analysis was conducted by Kyoto Encyclopedia of Genes and Genomes (KEGG) database to detect pathway enriched genes. Pathway-related modules of pathway enriched genes were mined from the co-expression network. Then topological centralities (degree, closeness, stress and betweenness centrality) analyses for co-expression network and sub-networks were performed to explore hub genes. Validation of hub genes was carried out utilizing reverse transcription-polymerase chain reaction (RT-PCR) assays.
There were 129 nodes and 1229 edges in co-expression network. We obtained a total of 16 hub genes and 11 pathway-related modules. Module 17 (Bladder cancer module) was the most significant module, which comprising 9 of 16 hub genes and 6 pathway enriched genes, taking intersection elements (CAV1 and CCND1). RT-PCR results showed that both of CAV1 and CCND1 in high-grade osteosarcoma were significantly differentially expressed compared with normal controls.
This work may contribute to understanding the molecular pathogenesis and provide potential biomarkers for detections and effective therapies of high-grade osteosarcoma.
本文旨在基于网络拓扑中心性分析,识别在高级别骨肉瘤中定义的与通路相关的模块。
基于差异表达基因(DEGs),通过加权基因共表达网络分析(WGCNA)构建共表达网络。利用京都基因与基因组百科全书(KEGG)数据库进行通路富集分析,以检测通路富集基因。从共表达网络中挖掘通路富集基因的通路相关模块。然后对共表达网络和子网进行拓扑中心性(度、接近度、应力和介数中心性)分析,以探索枢纽基因。利用逆转录-聚合酶链反应(RT-PCR)检测对枢纽基因进行验证。
共表达网络中有129个节点和1229条边。我们总共获得了16个枢纽基因和11个通路相关模块。模块17(膀胱癌模块)是最显著的模块,包含16个枢纽基因中的9个和6个通路富集基因,取交集元素(CAV1和CCND1)。RT-PCR结果显示,与正常对照相比,高级别骨肉瘤中的CAV1和CCND1均有显著差异表达。
这项工作可能有助于理解分子发病机制,并为高级别骨肉瘤的检测和有效治疗提供潜在的生物标志物。